Page last updated: 2024-08-24

1,2-distearoyllecithin and Leukemia, Myeloid, Acute

1,2-distearoyllecithin has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bunte, RM; Chiu, GN; Chng, WJ; Ling, LU; Tan, KB1

Other Studies

1 other study(ies) available for 1,2-distearoyllecithin and Leukemia, Myeloid, Acute

ArticleYear
Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia.
    Nanomedicine (London, England), 2014, Volume: 9, Issue:11

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Ceramides; Cholesterol; Chromatography, Liquid; Drug Delivery Systems; Female; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Mice, SCID; Phosphatidylcholines; Sphingosine; Tandem Mass Spectrometry; U937 Cells; Xenograft Model Antitumor Assays

2014